Increase of ribavirin dose improves sustained virological response in HCV-genotype 1 patients with a partial response to peg-interferon and ribavirin

Increase of ribavirin dose improves sustained virological response in HCV-genotype 1 patients with a partial response to peg-interferon and ribavirin

Background and aim. In patients with chronic hepatitis C receiving Peg interferon/ribavirin (PEG-IFN/RBV) who do not achieve ≥ 2log-reduction in HCV-RNA at week 12 (null responders, NR) and in those with ≥ 2log-decrease but detectable at week 24 (partial responders, PR) the probability to achieve th...

Full description

Bibliographic Details
Main Authors: Fabio Conti, Ranka Vukotic, Stefania Lorenzini, Anna Riili, Carmela Cursaro, Alessandra Scuteri, Elisabetta Loggi, Silvia Galli, Giuliano Furlini, Mauro Bernardi, Pietro Andreone, MD.
Format: Article
Language:English
Published: Elsevier 2014-03-01
Series:Annals of Hepatology
Subjects:
Hepatitis C
Genotype 1
Antiviral treatment
High ribavirin dose
Partial responder
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119308828

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119308828

Similar Items